The first detailed descriptions of patients with rare muscle disease (acute form of myositis) with cutaneous lesions were reported by E. Wagner [1] in 1863 and P. Potain (1875) [2]. These authors introduced to the medical community a new group of IIMs, characterized by the damage of many skeletal muscles and by skin manifestations. These disorders are rare, but increasingly recognized. They have avariety of clinical manifestations, immunological abnormalities and courses, and form a diverse group of diseases with unclear causes. The most common forms of these disorders are dermatomyositis (DM) and polymyositis (PM) [3].
In 1887, Professor Hans Unvericht published a description of a peculiar muscle disease with fatigue and malaise, muscle pain and weakness, swelling of face, and bluish lesions over eyelids [4]. He reported a 27-year-old stonemason, who developed acute onset of weakness, stiffness, and pain in the proximal arm, leg, and back muscles. A week later, diffuse swelling of face and extremities, accompanied by a low-grade evening fevers and a bluish rash over his eyelids, had developed. Over the next few days the patient noticed shortness of breath, thickening of the voice, and dysphagia. After several weeks, the patient died with cyanosis and clinical manifestation of a pulmonary arrest. Autopsy showed fluid-filled lungs and swollen proximal muscles. Histopathological examination showed various stages of degeneration of muscle fibers, and focal round-cell interstitial infiltration of the affected muscles. In 1891, Unvericht reported a second case and gave a name to this disorder — dermatomyositis [5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wagner E. Fall einer seltnen Muskelkrankheit. Dtsch Arch Heilk 1863; 4: 282–283.
Poten PC. Morve chronique de forme anormal. Bull et Mem Hop Paris 1875; 12: 314–318.
Bohan A, Peter JB. Polymyositis and dermatomyositis (part 1). N Engl J Med 1975; 292: 344–347.
Unverricht H. Polymyositis acuta progressive. Z Klin Med 1887; 12: 553.
Unverricht H. Dermatomyositis acuta. Dtsch Med Wochenschr 1891; 17: 41–44.
Unverricht H. Über eine eigenthümliche Form von akuter Muskelentzündung mit einem der Trichinose-ähnelnden Krankheitsbilde. Müncher Med Wochnschrf 1887; 34: 488–492.
Hepp P. Über einen Fall von acuter parenhymatoser Myositis, welche Geschwulste bildete und Fluctuation vortauschte. Berlin Klin Wochenschr 1887; 24: 389.
Jackson H. A case of acute, infectious universal myositis. Boston Med Surg J 1887; 116: 498.
Wagner E. Fall einer seltenen Muskelkrankheit. Arch Heikd 1886; 4: 242.
Wagner E. Ein Fall von acuter Polymyositis. Dtsch Arch Klin Med 1886–1887; 11: 241.
Jacobi E. Fall für Diagnose (Poikilodermia vascularis atrophicans). Verh Dtsch Dermatol Ges 1907; 9: 321–323.
Stertz G. Polymyositis. Berl Klin Wochenshr 1916; 53: 489.
Kankeleit H. Über primaire nichteitrige Polymyositis. Dtsch Arch Klin Med. 1916; 120: 335–339.
Patjes G, Clejat C. Sclerose atrophic de la peau et myosite. Ann Derm et Syphil Paris 1926; 550–568.
Gottron H. Hautveränderungen bei Dermatomyositis. VIII Congres Intern. Dermatol. et Syphilogr., Copenhagen, 5–8 Agout, 1930, Compt rend Seancy, Ed. S.Lomholt, Copenhagen 1931; 826–830.
Mills JA. Dermatomyositis. In: Dermatology in General Medicine, Fitzpatrick TB, Eisen AZ, Wolff K, et al. (eds), McGraw-Hill, New York, 1993; 2148–2155.
Hecht MS. Dermatomyositis in children. J Pediatr 1940; 17: 791.
Wedgwood RJ, Cook CD, Cohen J. Dermatomyositis: report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 1953; 12: 447–466.
Everett MA, Curtis AC. Dermatomyositis: a review of 19 cases in adolescents and children. Arch Intern Med 1957; 100: 70–76.
Banker B, Viktor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966; 45: 261–289.
Keil H. The manifestations in the skin and mucus membranes in dermatomyositis with special reference to the differential diagnosis from systemic lupus erythematosus. Ann Intern Med 1942; 16: 827.
Ganev V. Dermatomyositis. Bulg Clin 1941; 13(1): 1–15 [Bulgarian].
Popov L. Dermatomyositis (Morbus Wagner-Potain). Bulg Clin 1943; 15(3): 117–139 [Bulgarian].
Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255–286.
Caro I. Dermatomyositis as a systemic disease. Med Clin North Am 1989; 73: 1181–1192.
Krain LS. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol 1975; 111: 241–246.
Pearson CM. Polymyositis and dermatomyositis. In: Arthritis (and Allied Conditions), McCarty DJ (ed.), 9th ed. Lea & Febiger, Philadelphia, 1979; 742.
Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991; 24: 959–966
Blaszczyk M, Jablonska S, Szymanska-Jagiello W, et al. Childhood sclero-myositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 1991; 8: 1–8.
Basset-Seguin N, Roujeau JC, Gherardi R, et al. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990; 126: 633–637.
Chapurlat R, Tebib JG, Noel E, et al. Dermatomyosite induite par la d-penicillamine au cours d'une polyarthrite rheumatoide. Rheumatologie 1995; 47: 203–207.
Love LA, Feff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient group. Medicine 1991; 70: 360–374.
Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: 881–888.
Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28: 796–803.
Targoff IN, Johnson AE, Miller F W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990; 33: 1361–1370.
Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993; 100: 116s–123s.
Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M. The Jo-1 antibody system in myositis. Relationships to clinical features and HLA. J Rheumatol 1981; 8: 925–930.
Nilasena DS, Trieu E P, Targoff IN. Analysis of the MI-2 autoantigen of dermatomyositis. Arthritis Rheum 1995; 38: 123–128.
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). History of Dermatomyositis. In: Dermatomyositis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79313-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-79313-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79312-0
Online ISBN: 978-3-540-79313-7
eBook Packages: MedicineMedicine (R0)